Marshall Wace’s NantHealth, Inc NH Stock Holding History

Marshall Wace’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,211	Closed	-$58K	–	3351
2021 Q1	$58K	Buy	+1,211	New	+$70.2K	﹤0.01%	2387

Other funds holding NH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace's NH Position: Q2 2021 in Review

Marshall Wace sold out of NantHealth, Inc (NH) in Q2 2021, closing a stake of 1,211 shares — an estimated $58K sold.

Marshall Wace first reported a position in NH in Q1 2021 and held it in 1 quarter. The position peaked at $58K in Q1 2021. 45 funds tracked by Wall St. Rank hold NH as of Q2 2021.

Marshall Wace reported no remaining NantHealth, Inc position as of Q2 2021 after selling out during the quarter.
Marshall Wace sold 1,211 NantHealth, Inc shares in Q2 2021, an estimated $58K.
Marshall Wace first reported a position in NantHealth, Inc in Q1 2021 and held it in 1 quarter.
Marshall Wace's NantHealth, Inc position peaked at $58K in Q1 2021.
45 funds tracked by Wall St. Rank held NantHealth, Inc as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.